These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20613873)

  • 1. Protection against bronchiolitis obliterans syndrome is associated with allograft CCR7+ CD45RA- T regulatory cells.
    Gregson AL; Hoji A; Palchevskiy V; Hu S; Weigt SS; Liao E; Derhovanessian A; Saggar R; Song S; Elashoff R; Yang OO; Belperio JA
    PLoS One; 2010 Jun; 5(6):e11354. PubMed ID: 20613873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome.
    Bhorade SM; Chen H; Molinero L; Liao C; Garrity ER; Vigneswaran WT; Shilling R; Sperling A; Chong A; Alegre ML
    Transplantation; 2010 Sep; 90(5):540-6. PubMed ID: 20628341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung T-Cell Profile Alterations are Associated with Bronchiolitis Obliterans Syndrome in Cystic Fibrosis Lung Transplant Recipients.
    Hayes D; Harhay MO; Nicol KK; Liyanage NPM; Keller BC; Robinson RT
    Lung; 2020 Feb; 198(1):157-161. PubMed ID: 31807920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung function early after lung transplantation is correlated with the frequency of regulatory T cells.
    Nakagiri T; Warnecke G; Avsar M; Thissen S; Kruse B; Kühn C; Ziehme P; Knöfel AK; Madrahimov N; Okumura M; Sawa Y; Gottlieb J; Simon AR; Haverich A; Strüber M
    Surg Today; 2012 Feb; 42(3):250-8. PubMed ID: 22173646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation.
    Krustrup D; Iversen M; Martinussen T; Schultz HH; Andersen CB
    Clin Transplant; 2015 Mar; 29(3):179-84. PubMed ID: 25533723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased tumor-infiltrating CD45RA
    Mao FY; Kong H; Zhao YL; Peng LS; Chen W; Zhang JY; Cheng P; Wang TT; Lv YP; Teng YS; Fu XL; Liu YG; Wu XL; Hao CJ; You N; Luo P; Yu PW; Zou QM; Guo G; Zhuang Y
    Cell Death Dis; 2017 Aug; 8(8):e3002. PubMed ID: 28817117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High circulating CD4
    Durand M; Lacoste P; Danger R; Jacquemont L; Brosseau C; Durand E; Tilly G; Loy J; Foureau A; Royer PJ; Tissot A; Roux A; Reynaud-Gaubert M; Kessler R; Mussot S; Dromer C; Brugière O; Mornex JF; Guillemain R; Claustre J; Degauque N; Magnan A; Brouard S;
    J Heart Lung Transplant; 2018 Jun; 37(6):770-781. PubMed ID: 29571601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.
    Todd JL; Wang X; Sugimoto S; Kennedy VE; Zhang HL; Pavlisko EN; Kelly FL; Huang H; Kreisel D; Palmer SM; Gelman AE
    Am J Respir Crit Care Med; 2014 Mar; 189(5):556-66. PubMed ID: 24471427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution.
    Bergantini L; d'Alessandro M; De Vita E; Perillo F; Fossi A; Luzzi L; Paladini P; Perrone A; Rottoli P; Sestini P; Bargagli E; Bennett D
    Cells; 2021 Apr; 10(4):. PubMed ID: 33916034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal comparisons of lymphocytes and subtypes between airway wall and bronchoalveolar lavage after human lung transplantation.
    Zheng L; Orsida B; Whitford H; Levvey B; Ward C; Walters EH; Williams TJ; Snell GI
    Transplantation; 2005 Jul; 80(2):185-92. PubMed ID: 16041262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation.
    Fisichella PM; Davis CS; Lowery E; Ramirez L; Gamelli RL; Kovacs EJ
    J Am Coll Surg; 2013 Jul; 217(1):90-100; discussion 100-1. PubMed ID: 23628225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors.
    Meloni F; Morosini M; Solari N; Bini F; Vitulo P; Arbustini E; Pellegrini C; Fietta AM
    Int Immunopharmacol; 2006 Dec; 6(13-14):2002-10. PubMed ID: 17161354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction.
    Kaza V; Zhu C; Terada LS; Wang L; Torres F; Bollineni S; Mohanka M; Banga A; Joerns J; Mohanakumar T; Li QZ
    Hum Immunol; 2021 Jan; 82(1):25-35. PubMed ID: 33129576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD45RA-Foxp3(high) activated/effector regulatory T cells in the CCR7 + CD45RA-CD27 + CD28+central memory subset are decreased in peripheral blood from patients with rheumatoid arthritis.
    Matsuki F; Saegusa J; Miyamoto Y; Misaki K; Kumagai S; Morinobu A
    Biochem Biophys Res Commun; 2013 Sep; 438(4):778-83. PubMed ID: 23747721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential cytokine, chemokine and growth factor expression in phenotypes of chronic lung allograft dysfunction.
    Verleden SE; Ruttens D; Vos R; Vandermeulen E; Moelants E; Mortier A; Van Raemdonck DE; Proost P; Schols D; Verleden GM; Vanaudenaerde BM
    Transplantation; 2015 Jan; 99(1):86-93. PubMed ID: 25050473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of class II major histocompatibility complex antigens (HLA-DR) and lymphocyte subset immunotyping in chronic pulmonary transplant rejection.
    Hasegawa S; Ockner DM; Ritter JH; Patterson GA; Trulock EP; Cooper JD; Wick MR
    Arch Pathol Lab Med; 1995 May; 119(5):432-9. PubMed ID: 7748071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory virus-induced dysregulation of T-regulatory cells leads to chronic rejection.
    Bharat A; Kuo E; Saini D; Steward N; Hachem R; Trulock EP; Patterson GA; Meyers BF; Mohanakumar T
    Ann Thorac Surg; 2010 Nov; 90(5):1637-44; discussion 1644. PubMed ID: 20971279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
    Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker.
    LaPar DJ; Burdick MD; Emaminia A; Harris DA; Strieter BA; Liu L; Robbins M; Kron IL; Strieter RM; Lau CL
    Ann Thorac Surg; 2011 Aug; 92(2):470-7; discussion 477. PubMed ID: 21801908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection.
    Bharat A; Narayanan K; Street T; Fields RC; Steward N; Aloush A; Meyers B; Schuessler R; Trulock EP; Patterson GA; Mohanakumar T
    Transplantation; 2007 Jan; 83(2):150-8. PubMed ID: 17264811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.